ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Experimental Pharmacology and Drug Discovery
Opioid-Free Anesthesia with Esketamine Combined with Interpectoral Plane Block and Pectoralis-Serratus Plane Blocks in Radical Mastectomy: A Randomized Controlled Trial
Provisionally accepted- 1Xuzhou Central Hospital, Xuzhou, China
 - 2The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China
 - 3The Xuzhou Clinical College of Xuzhou Medical University, Xuzhou Central Hospital, Xuzhou, China
 - 4Xuzhou Medical University Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou, China
 
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: Opioid-free anesthesia (OFA) is an emerging technique that aims to reduce or eliminate intraoperative opioid use. Previous studies have shown that OFA is associated with reduced postoperative opioid consumption and fewer adverse events. This study investigated the impact of OFA on the quality of recovery (QoR) in patients undergoing radical mastectomy for breast cancer. Methods: We enrolled 130 patients scheduled for radical mastectomy and randomly assigned them to either the opioid-free anesthesia (OFA) group or the opioid-based anesthesia (OA) group. Data from 124 patients were ultimately analyzed. The primary outcome was the Quality of Recovery-40 (QoR-40) score at 24 and 48 hours postoperatively. Secondary outcomes included the Numerical Rating Scale (NRS) pain scores at 30 minutes, 24 hours, and 48 hours postoperatively, perioperative hemodynamic parameters, post-anesthesia care unit (PACU) stay duration, and the incidence of related adverse events. Results: Postoperative QoR-40 scores were significantly higher in the OFA group than in the OA group at both 24h (176.1 ± 3.7 vs 169.7 ± 3.3; mean difference 6.4, 95% CI 5.2-7.7, p<0.001) and 48h (180.3 ± 2.7 vs 173.7 ± 3.6; mean difference 6.6, 95% CI 5.5-7.7, p<0.01). The OFA group showed significantly lower pain scores on the Numeric Rating Scale (NRS) at all measured time points (30 min: 1.89 ± 0.8 vs 2.36 ± 1.2; 24h: 1.21 ± 0.6 vs 1.66 ± 0.8; 48h: 1.03 ± 0.4 vs 1.28 ± 0.6, all p<0.05). No statistically significant differences were observed in hemodynamic parameters, including mean arterial pressure (MAP) and heart rate (HR), at the following time points: upon entering the operating room (T0), before anesthesia induction (T1), before tracheal intubation (T2), immediately after tracheal intubation (T3), at skin incision (T4), 10 minutes after incision (T5), and upon leaving the operating room (T6). However, the incidence of postoperative nausea and vomiting (PONV) differed significantly between the two groups at 30 min, 24h, and 48h postoperatively (p< 0.05). Conclusion:For patients undergoing radical mastectomy, opioid-free anesthesia (OFA) utilizing esketamine combined with Interpectoral Plane (IPP) and Pectoralis-Serratus Plane (PSP) blocks significantly improved postoperative recovery quality compared to conventional opioid-based anesthesia (OA).
Keywords: Esketamine, Opioid-free anesthesia, interpectoral plane block, pectoralis-serratus plane block, Quality of recovery
Received: 04 Aug 2025; Accepted: 04 Nov 2025.
Copyright: © 2025 Ding, Deng, Sun, Wang, Liu, Zhang, Zhou, Liu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: 
Yan  Liu, dwp403469791@163.com
Liwei  Wang, doctorlww@sina.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
